If you could vote on Brexit now which option would you choose?
   

Philippines approves emergency use of Novavax COVID-19 vaccine


The Philippines has approved the emergency use of a COVID-19 vaccine by Novavax Inc, its food and drug agency chief said on Wednesday, the ninth vaccine approved in the Southeast Asian country. The nanoparticle vaccine, under the brand name Covovax, will be manufactured by Serum Institute of India, and is approved for use on adults 18 and above, the agency's chief Rolando Enrique Domingo told a public briefing. Covovax, which had efficacy of 89.7% in clinical trials, will be administered in two doses not less than 21 days apart, Domingo added.

Reuters - November 17, 2021

View the full story here: https://www.reuters.com/business/healthcare-pharmaceuticals/philippines-approves-emergency-use-novavaxs-covid-19-vaccine-2021-11-17/